Advertisement
Product › Details
Aranesp®
Next higher product group | darbepoetin alpha | |
Status | 2001-06-08 registration start | |
Organisation | Amgen Europe B.V. | |
Group | Amgen (Group) | |
Organisation 2 | Amgen Inc. (Nasdaq: AMGN) | |
Group | Amgen (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for anti-anemic drug
- [1] Disc Medicine. (10/29/19). "Press Release: Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production". Cambridge, MA....
- [2] Disc Medicine. (10/29/19). "Press Release: Disc Medicine Expands Pipeline Focused on Hepcidin Pathway. Enters into Exclusive Agreement with AbbVie for Series of Hemojuvelin Antagonist Monoclonal Antibodies". Cambridge, MA....
- [3] AstraZeneca plc. (8/22/19). "Press Release: Roxadustat Approved in China for the Treatment of Anaemia in Non-dialysis-dependent Patients with Chronic Kidney Disease"....
- [4] GlaxoSmithKline plc. (8/21/19). "Press Release: GSK Submits First Regulatory Application for Daprodustat in Japan for Patients with Renal Anaemia Due to Chronic Kidney Disease". London....
- [5] GlaxoSmithKline plc. (11/22/18). "Press Release: GSK and Kyowa Hakko Kirin Sign Strategic Commercialisation Deal in Japan for Daprodustat, a Potential New Oral Treatment for Anaemia Associated with Chronic Kidney Disease". London....
- [6] Servier. (11/3/17). "Press Release: Egis Intensifies Its Acquisition Strategy in 2017"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top